Human IL13RA2/CD213a2/IL13BP/IL13R2 Protein, ECD (Extracellular Domain), Fc-fusion, Recombinant
IL13RA2 (Interleukin-13 receptor subunit alpha-2), also known as CD213a2 and IL13BP (IL13-binding protein), is a single-pass type I transmembrane protein belonging to the type I cytokine receptor family. Like IL13RA1, the extracellular domain (ECD) of IL13RA1 contains 3 fibronectin type III domains, D1, D2, and D3, of which the last two comprise the cytokine receptor homology modules (CRHs). In contrast to IL13RA1, IL13RA2 binds IL-13 with a high affinity but lacks cytoplasmic domain, and does not appear to function as a signal mediator. IL-13RA2 is widely expressed and detected on many types of cancer cells including glioblastoma, AIDS Kaposi's sarcoma, and head & neck cancer. IL-13 binds two types of receptor: (1) a heterodimer of the IL13 RA1 and the IL4RA, transducing the IL13-dependent proliferative signal; and (2) the IL13RA2, acting as a nonsignaling "decoy" receptor by binding and internalizing IL13. IL13RA2 can also block IL4-induced responses by inhibiting IL4 bound IL13RA1/IL4RA receptor complexes even though it does not bind IL 4 directly. Aside from its decoy function, IL13-IL13RA2 binding directly promotes the development of tissue fibrosis. IL13RA2 may also play an important role in the Th2 polarized immune responses characteristic of a variety of pathologies, including parasitic infections and allergic asthma. IL-13Rα2 exists both on the cell membrane and in soluble form which are generated from distinct transcripts.
Gene Symbol: IL13RA2; CD213a2; IL-13RA2; IL13BP; IL13R2
NCBI Gene ID: 3598
Uniprot Entry: Q14627
Construct Details: The recombinant human IL13RA2-Fc fusion is expressed as a 552 amino acid protein consisting of Asp27 - Thr340 region of IL13RA2 and a C-terminal Fc from human IgG1, which exists as a dimer under non-reducing conditions.
Source: Human cells stably expressing human IL13RA2-Fc and growing in chemical-defined media with no animal components or antibiotics
Deduced Amino Acid Sequence:
10 20 30 40 50 60
DTEIKVNPPQ DFEIVDPGYL GYLYLQWQPP LSLDHFKECT VEYELKYRNI GSETWKTIIT
70 80 90 100 110 120
KNLHYKDGFD LNKGIEAKIH TLLPWQCTNG SEVQSSWAET TYWISPQGIP ETKVQDMDCV
130 140 150 160 170 180
YYNWQYLLCS WKPGIGVLLD TNYNLFYWYE GLDHALQCVD YIKADGQNIG CRFPYLEASD
190 200 210 220 230 240
YKDFYICVNG SSENKPIRSS YFTFQLQNIV KPLPPVYLTF TRESSCEIKL KWSIPLGPIP
250 260 270 280 290 300
ARCFDYEIEI REDDTTLVTA TVENETYTLK TTNETRQLCF VVRSKVNIYC SDDGIWSEWS
310 320 330 340 350 360
DKQCWEGEDL SKKTSTTENL YFQGSTGTHT CPPCPAPELL GGPSVFLFPP KPKDTLMISR
370 380 390 400 410 420
TPEVTCVVVD VSHEDPEVKF NWYVDGVEVH NAKTKPREEQ YNSTYRVVSV LTVLHQDWLN
430 440 450 460 470 480
GKEYKCKVSN KALPAPIEKT ISKAKGQPRE PQVYTLPPSR EEMTKNQVSL TCLVKGFYPS
490 500 510 520 530 540
DIAVEWESNG QPENNYKTTP PVLDSDGSFF LYSKLTVDKS RWQQGNVFSC SVMHEALHNH
550
YTQKSLSLSP GK
M.W.: Calculated molecular mass (kDa): 63.4; Estimated by SDS-PAGE under reducing condition (kDa): ~90
Calculated PI: 5.23
Calculated extinction coefficients (M-1 cm-1, at 280nm): 136805
Purity: >90% judged by SDS-PAGE under reducing condition (see the gel image above, labeled as "DTT: +")
Formulation: Supplied at 0.5 mg/ml in sterile PBSpH7.4 (carrier & preservative free).
Endotoxin Level: <0.1 EU per 1 μg of purified recombinant protein determined by the LAL method
Biological Activity: Binds to its human ligand IL13/IL4 and blocks IL13/IL4-induced signaling activity and proliferation of human erythroleukemic cells.
FOR RESEARCH USE ONLY. NOT FOR DIAGNOSTIC OR THERAPEUTIC USE IN HUMAN.
Restriction: This product is not transferable or re-sellable. Customer obtain no right to transfer, assign, or sublicense its use rights, or to transfer, resell, package, or otherwise distribute the product, or to use the product for the benefit of any third party or for any commercial purpose. Customer may only use the product in compliance with applicable local, state and federal laws, regulations and rules. Customer may not directly or indirectly use the product or allow the transfer, transmission, export or re-export of all or any part of the product in violation of any export control law or regulation of the united states or any other relevant jurisdiction. Your use of this product constitutes acceptance of the terms of this limited use agreement. Please refer to our “terms & conditions” for details. If you are not willing to accept the limitation of this agreement, G&P Biosciences will accept return of the product for a full/partial refund.
The product is shipped at 4°C. Upon receipt, centrifuge the product briefly before opening the vial. It is recommended to store small aliquots at the temperature below –20°C for long-term storage and the product is stable for 6 months.
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
FOR RESEARCH USE ONLY. NOT FOR DIAGNOSTIC OR THERAPEUTIC USE IN HUMAN.
1. J. Biol. Chem. 271:16921 (1996).
2. J. Immunol. 177:7905 (1998)
3. Annu. Rev. Immunol. 21:425 (2003).
4. Curr. Allergy Asthma Rep. 7:338 (2007).
5. J. Allergy Clin. Immunol. 122:625 (2008).
Product datasheet (pdf) can be downloaded here: FCL2454-PDS.pdf
Additional supporting documents, including COA and MSDS are available upon request.
FOR RESEARCH USE ONLY. NOT FOR DIAGNOSTIC OR THERAPEUTIC USE IN HUMAN.
Restriction: This product is not transferable or re-sellable. Customer obtain no right to transfer, assign, or sublicense its use rights, or to transfer, resell, package, or otherwise distribute the product, or to use the product for the benefit of any third party or for any commercial purpose. Customer may only use the product in compliance with applicable local, state and federal laws, regulations and rules. Customer may not directly or indirectly use the product or allow the transfer, transmission, export or re-export of all or any part of the product in violation of any export control law or regulation of the united states or any other relevant jurisdiction. Your use of this product constitutes acceptance of the terms of this limited use agreement. Please refer to our “terms & conditions” for details. If you are not willing to accept the limitation of this agreement, G&P Biosciences will accept return of the product for a full/partial refund.